Trial
NCT00531271
ABI-008 Trial in Patients With Metastatic Breast Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Celgene
Collaborators
—
Condition
Metastatic Breast Cancer
Intervention
ABI-008 (nab-docetaxel)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-14